{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:24:19Z","timestamp":1780547059510,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2211,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 CA133117"],"award-info":[{"award-number":["R01 CA133117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1 CA119078"],"award-info":[{"award-number":["RO1 CA119078"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01 CA152990, P50 CA105009"],"award-info":[{"award-number":["U01 CA152990, P50 CA105009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21 CA156021"],"award-info":[{"award-number":["R21 CA156021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Ovarian Cancer Research Fund"},{"name":"the Adelson Medical Research Foundation"},{"DOI":"10.13039\/100000983","name":"the Mary Kay Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000983","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Robert and Debra First Fund"},{"name":"the Gamel Ovarian Cancer Research Fund"},{"name":"the Honorable Tina Brozman Foundation"},{"name":"the Ovarian Cancer Coalition of Greater California"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1093\/annonc\/mdt308","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T14:26:35Z","timestamp":1381933595000},"page":"viii28-viii35","source":"Crossref","is-referenced-by-count":83,"special_numbering":"S8","title":["Coming into focus: the nonovarian origins of ovarian cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"L.","family":"Dubeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdt308_bb0010","series-title":"World cancer report 2008","author":"Boyle","year":"2008"},{"key":"10.1093\/annonc\/mdt308_bb0015","first-page":"816","article-title":"Ein prim\u00e3res carcinoma papillare tubae dextrae, verbunden mit ovarial-abscess","volume":"10","author":"Orthmann","year":"1886","journal-title":"Centrabl f Gyn\u00e3k"},{"key":"10.1093\/annonc\/mdt308_bb0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1097-0142(194909)2:5<803::AID-CNCR2820020510>3.0.CO;2-K","article-title":"Primary and metastatic cancer of the fallopian tube","volume":"2","author":"Finn","year":"1949","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt308_bb0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/1097-0142(197004)25:4<947::AID-CNCR2820250432>3.0.CO;2-O","article-title":"Ultrastructure of ovarian tumors. I. Papillary serous cystadenocarcinoma","volume":"25","author":"Roberts","year":"1970","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt308_bb0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jcb.240590928","article-title":"Pathology of ovarian cancer precursors","volume":"23","author":"Scully","year":"1995","journal-title":"J Cell Biochem Suppl"},{"key":"10.1093\/annonc\/mdt308_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2009.10.003","article-title":"Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review","volume":"75","author":"Pentheroudakis","year":"2010","journal-title":"Crit Rev Hematol\/Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO;2-G","article-title":"Ovarian carcinogenesis and the biology of the ovarian surface epithelium","volume":"173","author":"Auersperg","year":"1997","journal-title":"J Cell Physiol"},{"key":"10.1093\/annonc\/mdt308_bb0045","first-page":"47","article-title":"Ovarian cystomas of germinal epithelial origin-a histogenetic classification","volume":"55","author":"Hertig","year":"1958","journal-title":"Rocky Mt Med J"},{"key":"10.1093\/annonc\/mdt308_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-1-70","article-title":"Ovarian surface epithelium: family history and early events in ovarian cancer","volume":"1","author":"Wong","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1093\/annonc\/mdt308_bb0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2008.05.031","article-title":"The origin of ovarian cancer: a developmental view","volume":"110","author":"Auersperg","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ydbio.2006.09.046","article-title":"The origin of the Mullerian duct in chick and mouse","volume":"302","author":"Guioli","year":"2007","journal-title":"Dev Biol"},{"key":"10.1093\/annonc\/mdt308_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ydbio.2007.03.027","article-title":"Cellular mechanisms of Mullerian duct formation in the mouse","volume":"306","author":"Orvis","year":"2007","journal-title":"Dev Biol"},{"key":"10.1093\/annonc\/mdt308_bb0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdt308_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0046-8177(99)90269-1","article-title":"Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer","volume":"30","author":"Werness","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0080","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0085","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0120","first-page":"296","article-title":"The role of the fallopian tube in ovarian cancer","volume":"10","author":"Tone","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0125","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm1196-1179","article-title":"Frequency of recurrent BRCA1 and BRCA2 mutations in 222 Ashkenazi Jewish breast cancer families","volume":"2","author":"Tonin","year":"1996","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdt308_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1093\/annonc\/mdt308_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdt308_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdt308_bb0145","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"21","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0150","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt308_bb0155","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","article-title":"Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis","volume":"35","author":"Kurman","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0160","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e318233b0f7","article-title":"Fallopian tube correlates of ovarian serous borderline tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0165","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of \u2018ovarian\u2019 low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Modern Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0170","series-title":"Blaustein's Pathology of the Female Genital Tract","author":"Kurman","year":"2011"},{"key":"10.1093\/annonc\/mdt308_bb0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004347-199401000-00009","article-title":"The secondary mullerian system revisited","volume":"13","author":"Lauchlan","year":"1994","journal-title":"Int J Gynecol Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0180","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumors","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/gyno.2000.6066","article-title":"K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary","volume":"80","author":"Alvarez","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.pgp.0000092155.33490.52","article-title":"Serous tumor of low malignant potential arising in inguinal endosalpingiosis: report of a case","volume":"22","author":"Carrick","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2559.1983.tb02272.x","article-title":"Papillary serous cystadenoma of borderline malignancy arising in a paraovarian paramesonephric cyst. Light microscopic and ultrastructural observations","volume":"7","author":"Chandraratnam","year":"1982","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/mdt308_bb0200","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/gyno.1995.9955","article-title":"Possible metaplastic origin of lymph node \"metastases\" in serous ovarian tumor of low malignant potential (borderline serous tumor)","volume":"59","author":"Kadar","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0205","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1053\/hupa.2002.127437","article-title":"Mullerian papilloma-like proliferation arising in cystic pelvic endosalpingiosis","volume":"33","author":"McCluggage","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004347-199501000-00015","article-title":"Borderline and malignant serous tumor arising in pelvic lymph nodes: evidence of origin in benign glandular inclusions","volume":"14","author":"Prade","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0215","first-page":"132","article-title":"A simplified method to culture human ovarian surface epithelium","volume":"63","author":"Kruk","year":"1990","journal-title":"Lab Invest"},{"key":"10.1093\/annonc\/mdt308_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yexcr.2006.09.026","article-title":"Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes","volume":"313","author":"Clark-Knowles","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1093\/annonc\/mdt308_bb0225","first-page":"1389","article-title":"Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer","volume":"63","author":"Connolly","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt308_bb0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nm1173","article-title":"Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer","volume":"11","author":"Dinulescu","year":"2005","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdt308_bb0235","first-page":"3459","article-title":"Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium","volume":"63","author":"Nikitin","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt308_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1535-6108(01)00002-2","article-title":"Induction of ovarian cancer by defined multiple genetic changes in a mouse model system","volume":"1","author":"Orsulic","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1093\/annonc\/mdt308_bb0245","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-11-3834","article-title":"Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer","volume":"72","author":"Szabova","year":"2012","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt308_bb0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/b-catenin and PI3 K\/Pten signaling pathways","volume":"11","author":"Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1093\/annonc\/mdt308_bb0255","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0260","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-07-4959","article-title":"Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma","volume":"14","author":"Tone","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdt308_bb0265","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1593\/neo.11138","article-title":"Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma","volume":"13","author":"Jazaeri","year":"2011","journal-title":"Neoplasia"},{"key":"10.1093\/annonc\/mdt308_bb0270","first-page":"22","article-title":"The new face of ovarian cancer modeling: better prospects for detection and treatment","volume":"3","author":"Karst","year":"2011","journal-title":"F1000 Med Reprod"},{"key":"10.1093\/annonc\/mdt308_bb0275","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdt308_bb0280","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.4161\/cc.20544","article-title":"Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications","volume":"11","author":"Shan","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1093\/annonc\/mdt308_bb0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0290","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congential hypothyroid female Pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"10.1093\/annonc\/mdt308_bb0295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"King","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mdt308_bb0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2013a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0305","first-page":"51","article-title":"Ex vivo culture of primary human fallopian tube epithelial cells","volume":"9","author":"Fotheringham","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1093\/annonc\/mdt308_bb0310","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdt308_bb0315","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.theriogenology.2011.04.021","article-title":"Modelling the porcine oviduct epithelium: a polarized in vitro system suitable for long-term cultivation","volume":"76","author":"Miessen","year":"2011","journal-title":"Theriogenology"},{"key":"10.1093\/annonc\/mdt308_bb0320","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/mdt308_bb0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/gyno.1997.4880","article-title":"Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases","volume":"67","author":"Luo","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdt308_bb0330","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/sj.bjc.6603817","article-title":"Increased chromosomal stability of ovarian tumors of low malignant potential compared to cystadenomas","volume":"96","author":"Yu","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdt308_bb0335","first-page":"5813","article-title":"Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells","volume":"63","author":"Velicescu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt308_bb0340","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/ijc.26309","article-title":"Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells","volume":"130","author":"Yu","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdt308_bb0345","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mrd.10175","article-title":"Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: tumor formation and its hormonal regulation","volume":"63","author":"Miyoshi","year":"2002","journal-title":"Molec Reprod Dev"},{"key":"10.1093\/annonc\/mdt308_bb0350","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncr.23956","article-title":"Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin","volume":"115","author":"Pearce","year":"2009","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdt308_bb0355","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdt308_bb0360","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cub.2005.01.052","article-title":"Cell-Nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional BRCA1 in ovarian granulosa cells","volume":"15","author":"Chodankar","year":"2005","journal-title":"Curr Biol"},{"key":"10.1093\/annonc\/mdt308_bb0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/0008-5472.CAN-09-3232","article-title":"Changes in the mouse estrus cycle in response to Brca1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer","volume":"70","author":"Hong","year":"2010","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdt308_bb0370","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/labinvest.2012.58","article-title":"Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen responsive organs","volume":"92","author":"Yen","year":"2012","journal-title":"Lab Invest"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419315911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419315911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/suppl_8\/viii28\/6675194\/mdt308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T03:31:40Z","timestamp":1582169500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419315911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":73,"alternative-id":["S0923753419315911"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdt308","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}